Abstract
Acute respiratory distress syndrome(ARDS) is a common critical syndrome with high morbidity and mortality.The treatments include respiratory support and drug therapy.In this paper, the latest clinical advances in the treatment of ARDS with glucocorticoids, statins, antioxidants, recombinant human activated protein C, sedatives and muscle relaxants, exogenous alveolar surfactants, mesenchymal stem cells, and vasodilators are reviewed. Key words: Respiratory distress syndrome, adult; Drug therapy; Glucocorticoids; Cystatins; Antioxidants; Pulmonary surfactant-associated proteins; Mesenchymal stem cells; Vasodilator agents; Review
Full Text
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call